http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-240010-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62b563909ed77d94afc3c237e0fbd935
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89
filingDate 1985-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e73942c3d6bf015b9f0008cd9d58cf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2d88159eafc7b6e4ce01d5f43bfc544
publicationDate 1986-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-240010-A1
titleOfInvention PROCESS FOR PREPARING SUBSTITUTED 2-IMINO-1H-PYRIDINE-1-AMINES
abstract The invention relates to a process for the preparation of substituted 2-imino-1H-pyridin-1-amines. Such compounds are important for the preparation of cardiovascular drugs. The aim of the invention is to make available substituted 2-imino-1H-pyridin-1-amines, starting from readily accessible and easily handled starting materials which do not yet contain a pyridine ring. According to the invention, this object is achieved by reacting 4-amino-1-cyano-butadiene- (1,3) with hydrazines advantageously in an organic solvent to give the substituted 2-imino-1H-pyridin-1-amines of general formula I. , The invention can be used in the chemical and pharmaceutical industries. Formula I
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1043472-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0584491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0592896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8357694-B2
priorityDate 1985-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426184532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11972264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420314932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426568638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454507293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73605669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11830845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420126324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529444

Total number of triples: 42.